Detailed answers about MEDDROID PHARMACEUTICALS LIMITED, including incorporation, status, business activity, and accounts information.
When was MEDDROID PHARMACEUTICALS LIMITED founded?
MEDDROID PHARMACEUTICALS LIMITED was officially incorporated on 20 January 2023 and is registered under company number 14607058. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is MEDDROID PHARMACEUTICALS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of MEDDROID PHARMACEUTICALS LIMITED?
MEDDROID PHARMACEUTICALS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does MEDDROID PHARMACEUTICALS LIMITED do?
MEDDROID PHARMACEUTICALS LIMITED operates in the following sectors: 21100 - Manufacture of basic pharmaceutical products, 46180 - Agents specialized in the sale of other particular products, 46460 - Wholesale of pharmaceutical goods, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is MEDDROID PHARMACEUTICALS LIMITED's registered address?
The registered office address of MEDDROID PHARMACEUTICALS LIMITED is 71-75 SHELTON STREET, COVENT GARDEN, LONDON, UNITED KINGDOM, WC2H 9JQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is MEDDROID PHARMACEUTICALS LIMITED financially stable?
The most recent accounts for MEDDROID PHARMACEUTICALS LIMITED were made up to 31 January 2026, filed as DORMANT. Next accounts are due by 31 October 2027.